Company
Xaar plc
Headquarters: Cambridge, United Kingdom
Founded: 1990
Employees: 388
CEO: Dr. Robert John Mills
Market Cap
£65.0 Million
GBP as of Jan. 1, 2025
US$81.6 Million
Top Competitors by Market Capitalization
Industry: Electronic Components
| Company | Market Cap (USD) |
|---|---|
| Amphenol | $94.70 B |
| Hon Hai Precision Industry Co. Ltd | $75.17 B |
| TE Connectivity Ltd. | $46.85 B |
| Corning Incorporated | $46.22 B |
| Delta Electronics, Inc. | $34.62 B |
Detailed Description
Xaar plc designs, develops, manufactures, markets, and sells printheads and associated products in Europe, the Middle East, Africa, Asia, and the Americas. It operates through Printhead and Product Print Systems segments. The company offers print head products, including Irix, Nitrox, Xaar 2002, Xaar 1003 C, Xaar 1003 U, Xaar 1003 AMx, Xaar 1003 Amp, Xaar 502 S, Xaar 502 O, Xaar 501, Xaar 128, and Xaar 2001+ U; and system components, such as ink system test kit, print manager, hydra ink supply system, midas ink supply system, inkjet development system, head personality card 3, and 2001+ head personality card, as well as industrial inkjet printers, F-Jet24 and bottle jet digital multi-pass scanning systems, and KP-KE analogue systems-pneumatic driven and servo-driven machines. Its products have applications in ceramic tile decoration, graphics, décor, labels and packaging, and additive manufacturing. The company was founded in 1990 and is headquartered in Cambridge, the United Kingdom.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | £70.6 M |
| EBITDA | £4.5 M |
| Gross Profit TTM | £26.9 M |
| Profit Margin | -3.08% |
| Operating Margin | -11.25% |
| Quarterly Revenue Growth | -0.20% |
Stocks & Indices
Xaar plc has the following listings and related stock indices.
Stock: LSE: XAR wb_incandescent
Key People
Andrew Herbert, (Chairman) John Mills, (CEO)